CD34 and type 2 diabetes mellitus: Therefore, studying CD34+ve cells in T2DM subjects with or without Canagliflozin can give vital information about the medication and its effect on hematopoetic stem cell pool that may have a long-term effect on future endothelium and other vascular cells.